Allscripts (NASDAQ: MDRX) reported Q4 EPS of $0.20, $0.01 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $538 million versus the consensus estimate of $563.83 million.

GUIDANCE:

Allscripts sees FY2019 EPS of $0.65-$0.70, versus the consensus of $0.81.

• First quarter 2019 non-GAAP revenue between $430 million and $440 million
• Full year 2019 bookings(1) between $900 million and $1,000 million

For earnings history and earnings-related data on Allscripts (MDRX) click here.